Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVS
NVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVS News
Novartis' Fabhalta Significantly Reduces Kidney Failure Risk
2d ago
Yahoo Finance
Eli Lilly's AI Investment: Implications for Its Stock Performance.
17h ago
Barron's
Novartis Proposes Acquisition of Excellergy to Expand Immunology Pipeline
3d ago
NASDAQ.COM
Novartis Acquires Excellergy to Enhance Immunology Strategy
3d ago
NASDAQ.COM
Novartis Acquires Excellergy for Up to $2B to Enhance Allergy Portfolio
3d ago
seekingalpha
Novartis Acquires Excellergy for Up to $2 Billion
3d ago
Yahoo Finance
Morgan Stanley Increases Novartis AG Target Price to $170, Up from $143
4d ago
moomoo
ON Holding Leadership Shakeup Amid Growth Slowdown
5d ago
Fool
Vanguard International High Dividend ETF Investment Advantages
6d ago
Fool
Vanguard International High Dividend ETF Investment Advantages
6d ago
NASDAQ.COM
Analysts Adjust Ratings on Tesla and Novartis Amid Market Concerns
6d ago
seekingalpha
Israeli Reopening of Strait of Hormuz Causes Stock Index Futures to Reverse Gains
Mar 20 2026
seekingalpha
Novartis Acquires Experimental Breast Cancer Drug from Synnovation for Up to $3B
Mar 20 2026
seekingalpha
Senhwa Biosciences Achieves Breakthrough in Photodynamic Therapy
Mar 17 2026
Yahoo Finance
Novartis Approves New Share Buyback Program
Mar 16 2026
seekingalpha
Novartis' Cosentyx Approved for Pediatric Use by FDA
Mar 16 2026
NASDAQ.COM
Show More News
